Screener
Context Therapeutics Inc. CNTX Q1 2025 earnings
Reported May 7, 2025 · Before market open
EPS-$0.05In line
EPS estimate-$0.05
Next report
Nov 4, 2026 (in 2 months)EPS estimate-$0.09
Versus estimates
FAQ
- When did Context Therapeutics Inc. report Q1 2025 earnings?
- Context Therapeutics Inc. (CNTX) reported Q1 2025 earnings on May 7, 2025 before market open.
- What were Context Therapeutics Inc.'s Q1 2025 revenue and EPS?
- Context Therapeutics Inc. reported eps of $-0.05 for Q1 2025.
- Did Context Therapeutics Inc. beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.05 by $0.00.
- How did Context Therapeutics Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 78.3% from $-0.23.
- Where can I find Context Therapeutics Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001842952-25-000048) directly on SEC EDGAR. The filing index links above go to sec.gov.
